Islets of Hope diabetes headline news

islets of hope home buttondiabetes law buttonchildren with diabetes, right to educationclincal trials, research, studies buttondiabetes type 1 and type 2 support groups type 1 diabetes informationtype 2 diabetes information

diabetes news headlines and research                                Business news archives


Stories and Headline News from the Diabetes Business Community

If you copy our list of links for your own site, we'd really appreciate it if you would add a link to our site as well.  Your support and mention of www.IsletsofHope.com will help others with diabetes.  We now donate 100% of the profits from our website to nonprofit diabetes organizations that purchase insulin, diabetes medications, and supplies for others in need.

Current Diabetes News Headlines                              Busines Archives Menu


April 2006

University of Southern California Named Sixth Participant in the Diabetes Ten City Challenge - 04/27/2006

University Of Michigan To Start Program That Would Give No-Cost, Discounted Medications To Employees, Dependents With Diabetes - 04/27/2006

University to research diabetes -  The University for the Highlands and Islands is planning to become a leader in the research of diabetes.  04/25/06

Transition Therapeutics Completes Target Enrolment for Type II Diabetes Clinical Trial of Lead Regenerative Product, - Transition Therapeutics Inc. , announces today the completion of target enrolment for an exploratory Phase IIa clinical trial of its lead regenerative therapy, E1-I.N.T., in type II diabetes patients and provides an update on the enrolment of patients in the type I diabetes clinical trial.  04/25/06

Satish Garg, MD Appointed New Editor-in-Chief of Leading Diabetes Technology Journal - Satish K. Garg, MD, Professor of Medicine and Pediatrics and Director, Adult Program, Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, has been appointed the new Editor-in-Chief of Diabetes Technology & Therapeutics, a MEDLINE journal published by Mary Ann Liebert, Inc., publishers, ... 04/24/06

Medisave usage approved for outpatient care of four chronic diseases (Singapore) - The use of Medisave will be allowed for outpatient care of four chronic diseases before the end of the year. These are diabetes, hypertension, lipid disorders and stroke.  04/17/06

Aldar's construction of Imperial College London Diabetes Centre completed ahead of schedule - ALDAR Properties PJSC announced today that construction of the city's specialist Diabetes Treatment & Research Centre has been completed ahead of schedule.  04/17/06

Emisphere Completes Enrollment For Phase II Oral Insulin Clinical Trial  (India) 04/16/06

Singapore's biotech pipeline show promise - Singapore is betting on a clutch of top international scientists to come up with new wonder drugs to combat diseases such as cancer, dengue and disorders including diabetes.  04/14/06

Medtronic gets OK for diabetes device - Medtronic Inc. has won government approval of a new system that helps diabetics continuously check their blood sugar levels, alerting them when levels edge too high or plunge too low. The company's Paradigm Real-Time system includes a glucose monitor that relays blood sugar information to the patient every five minutes from a sensor inserted under the skin and attached to a pager-size insulin.  04/14/06

Diabetes: Insulin Pump Also Monitors Blood Sugar  - The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump and glucose monitoring system, the first device to both deliver insulin and monitor a user's blood sugar in real time, the company said Thursday.  04/13/06

Chrysler Pilot Program Improves Health Of Diabetic Employees, Might Reduce Health Care Costs   04/12/06

MicroIslet cash runs low; firm to raise funds - MicroIslet, a company with an intriguing transplant technology but a thin bankroll, warned investors yesterday that it only has enough cash to fund operations through June.  04/12/06

Depomed Data Published in Diabetes Care on Glumetza, an FDA-Approved Treatment for Type II Diabetes -

Depomed, Inc. announced today that the results of its Phase III clinical trial with Glumetza, an FDA-approved, once-daily version of metformin for the treatment of Type II diabetes, were published in the April 2006 issue of Diabetes Care.  04/11/06

Torrent's diabetes division launches Pregeb and Piopod -Torrent Pharma's newly launched diabetes division, AzuCa, has launched two major blockbusters, Pregeb (Pregabalin) and Piopod (Pioglitazone).  04/10/06

Back to Top


Diabetes Headline News Resources

Contact Us  |  About IOH  |  Our Mission  |  Elizabeth's Story  |  About the Founder  |  Join IOH  |  How To Help  |  Advertise |  Privacy Statement  |  Site Index  |

Page Updated 10/01/2006